iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share

Earnings (Loss) Per Common Share

9 Months Ended

Mar. 31, 2014

9.	Earnings (Loss) Per Common Share

Basic earnings per share (“EPS”) per common share is computed by dividing the net income (loss) allocated to common stockholders by the weighted-average number of shares of common stock outstanding during the period. For purposes of calculating diluted EPS, the denominator includes the weighted-average number of shares of common stock outstanding during the period, the weighted-average effect of the 1.2 million shares from the private placement offering, and the number of common stock equivalents if the inclusion of such common stock equivalents is dilutive. Dilutive common stock equivalents potentially include stock options and warrants using the treasury stock method. The following table summarizes the components of the EPS calculation (in thousands, except per share amounts):

	Three Months ended March 31,				Nine Months ended March 31,
	2014		2013		2014		2013
Basic Numerator:

Net loss	$	(1,279)	$	(1,758)	$	(2,524)	$	(4,881)

Basic Denominator		65,642		47,767		62,080		47,767
Per Share Amount	$	(0.02)	$	(0.04)	$	(0.04)	$	(0.10)

For the three and nine months ended March 31, 2014 and 2013, the Company incurred net losses which cannot be diluted; therefore, basic and diluted loss per common share is the same. As of March 31, 2014, shares issuable which could potentially dilute future earnings included approximately 8.8 million stock options and 8.8 million warrants. As of March 31, 2013, shares issuable which could potentially dilute future earnings included approximately 6.7 million stock options and 21.0 million warrants.